CN106343566A - 一种慢性肾病患者用的特殊医用食品配方及其生产工艺 - Google Patents
一种慢性肾病患者用的特殊医用食品配方及其生产工艺 Download PDFInfo
- Publication number
- CN106343566A CN106343566A CN201610762760.5A CN201610762760A CN106343566A CN 106343566 A CN106343566 A CN 106343566A CN 201610762760 A CN201610762760 A CN 201610762760A CN 106343566 A CN106343566 A CN 106343566A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- sodium
- patients
- special medical
- medical food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 239000000203 mixture Substances 0.000 title claims abstract description 10
- 238000009472 formulation Methods 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title 1
- 208000017169 kidney disease Diseases 0.000 title 1
- 208000020832 chronic kidney disease Diseases 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 21
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 12
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 12
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims abstract description 12
- 229930006000 Sucrose Natural products 0.000 claims abstract description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019519 canola oil Nutrition 0.000 claims abstract description 10
- 239000000828 canola oil Substances 0.000 claims abstract description 10
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 8
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 8
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 8
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 6
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 6
- 229960002685 biotin Drugs 0.000 claims abstract description 6
- 235000020958 biotin Nutrition 0.000 claims abstract description 6
- 239000011616 biotin Substances 0.000 claims abstract description 6
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 6
- 235000010216 calcium carbonate Nutrition 0.000 claims abstract description 6
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 6
- 229910000365 copper sulfate Inorganic materials 0.000 claims abstract description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229960000304 folic acid Drugs 0.000 claims abstract description 6
- 235000019152 folic acid Nutrition 0.000 claims abstract description 6
- 239000011724 folic acid Substances 0.000 claims abstract description 6
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims abstract description 6
- 239000001095 magnesium carbonate Substances 0.000 claims abstract description 6
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims abstract description 6
- 235000014380 magnesium carbonate Nutrition 0.000 claims abstract description 6
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims abstract description 6
- 239000004137 magnesium phosphate Substances 0.000 claims abstract description 6
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims abstract description 6
- 229960002261 magnesium phosphate Drugs 0.000 claims abstract description 6
- 235000010994 magnesium phosphates Nutrition 0.000 claims abstract description 6
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 6
- 229940099596 manganese sulfate Drugs 0.000 claims abstract description 6
- 239000011702 manganese sulphate Substances 0.000 claims abstract description 6
- 235000007079 manganese sulphate Nutrition 0.000 claims abstract description 6
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims abstract description 6
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims abstract description 6
- 229960005055 sodium ascorbate Drugs 0.000 claims abstract description 6
- 235000010378 sodium ascorbate Nutrition 0.000 claims abstract description 6
- 239000011775 sodium fluoride Substances 0.000 claims abstract description 6
- 235000013024 sodium fluoride Nutrition 0.000 claims abstract description 6
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 6
- 239000011781 sodium selenite Substances 0.000 claims abstract description 6
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 6
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims abstract description 6
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 6
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 6
- 239000011787 zinc oxide Substances 0.000 claims abstract description 5
- 235000014692 zinc oxide Nutrition 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 4
- 239000001103 potassium chloride Substances 0.000 claims abstract description 3
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 3
- 229940088594 vitamin Drugs 0.000 claims description 38
- 229930003231 vitamin Natural products 0.000 claims description 38
- 235000013343 vitamin Nutrition 0.000 claims description 38
- 239000011782 vitamin Substances 0.000 claims description 38
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 38
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 15
- -1 eleostearic acid ester Chemical class 0.000 claims description 10
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- 229940045997 vitamin a Drugs 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 235000012054 meals Nutrition 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 6
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 5
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 5
- 235000013734 beta-carotene Nutrition 0.000 claims description 5
- 239000011648 beta-carotene Substances 0.000 claims description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 5
- 229960002747 betacarotene Drugs 0.000 claims description 5
- 229960000359 chromic chloride Drugs 0.000 claims description 5
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- 239000011684 sodium molybdate Substances 0.000 claims description 5
- 235000015393 sodium molybdate Nutrition 0.000 claims description 5
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 claims description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 125000005456 glyceride group Chemical group 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 239000006188 syrup Substances 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 101800002326 Adipokinetic hormone Proteins 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- 235000002864 food coloring agent Nutrition 0.000 claims description 2
- 229920002050 silicone resin Polymers 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 239000002383 tung oil Substances 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- VDGJOQCBCPGFFD-UHFFFAOYSA-N oxygen(2-) silicon(4+) titanium(4+) Chemical compound [Si+4].[O-2].[O-2].[Ti+4] VDGJOQCBCPGFFD-UHFFFAOYSA-N 0.000 claims 1
- 229940080352 sodium stearoyl lactylate Drugs 0.000 claims 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 8
- 229910000358 iron sulfate Inorganic materials 0.000 abstract description 5
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 abstract description 5
- 239000011780 sodium chloride Substances 0.000 abstract description 4
- 235000002639 sodium chloride Nutrition 0.000 abstract description 4
- 230000004083 survival effect Effects 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 235000003715 nutritional status Nutrition 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 abstract 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 abstract 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract 1
- 235000009499 Vanilla fragrans Nutrition 0.000 abstract 1
- 244000263375 Vanilla tahitensis Species 0.000 abstract 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 abstract 1
- 229960004874 choline bitartrate Drugs 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 229960000355 copper sulfate Drugs 0.000 abstract 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 abstract 1
- 235000013681 dietary sucrose Nutrition 0.000 abstract 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 abstract 1
- 235000019175 phylloquinone Nutrition 0.000 abstract 1
- 239000011772 phylloquinone Substances 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 abstract 1
- 229960001898 phytomenadione Drugs 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960000342 retinol acetate Drugs 0.000 abstract 1
- 235000019173 retinyl acetate Nutrition 0.000 abstract 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 abstract 1
- 239000011770 retinyl acetate Substances 0.000 abstract 1
- 235000019172 retinyl palmitate Nutrition 0.000 abstract 1
- 229940108325 retinyl palmitate Drugs 0.000 abstract 1
- 239000011769 retinyl palmitate Substances 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 229960000414 sodium fluoride Drugs 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 abstract 1
- 229910001887 tin oxide Inorganic materials 0.000 abstract 1
- 229940042585 tocopherol acetate Drugs 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
- 229960001296 zinc oxide Drugs 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000005660 chlorination reaction Methods 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 2
- 229910000398 iron phosphate Inorganic materials 0.000 description 2
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- UKGRTCZMPQERFQ-UHFFFAOYSA-N octadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)O UKGRTCZMPQERFQ-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及了一种慢性肾病患者用的特殊医用食品配方及其生产工艺，包括麦芽糊精、植物性油粉、芥花油粉、菊糖、蔗糖、碳酸钙、氯化钠、香草精、碳酸镁、氯化钾、磷酸钙、碳酸氢钠、磷酸镁、二氧化锡、抗坏血酸钠、重酒石酸胆碱、乙酸维生素E、硫酸锌、硫酸铁、硫酸锰、焦磷酸铁、本多酸钙、氟化钠、维生素K1、维生素D3、硫酸铜、亚硒酸钠、维生素A棕桐酸酯、生物素、氧化锌、维生素B12、维生素B6、维生素B2、维生素B1、乙酸维生素A、叶酸。本产品低蛋白、高能量，能保证慢性肾脏病患者营养物质供给，显著改善CKD患者营养状况，延缓CKD进展，提高生活质量，提高生存率。
Description
技术领域
本发明属于慢性肾病患者用的特殊医用食品领域，具体地说是一种慢性肾病患者用的特殊医用食品配方及其生产工艺。
背景技术
中国肠内营养方兴未艾，肾科肠内营养制剂几乎空白。中国慢性肾脏病(CKD）总体患病率为10.8%，中国CKD患病人口高达1.195亿，28%-78%CKD病人存在蛋白质能量消耗（PEW）摄入量不足，影响生存率。 PEW是CKD患者死亡的独立影响因素，每年新增病人8%，28%-50%透析前CKD3-5期病人存在PEW，其中血透病人338K，腹透病人80k，78%透析病人存在PEW。所以急需一种慢性肾病患者用的特殊医用食品配方及其生产工艺来解决上述问题。
发明内容
针对上述现有技术不足，本发明提供一种慢性肾病患者用的特殊医用食品配方及其生产工艺。
本发明提供的一种慢性肾病患者用的特殊医用食品配方及其生产工艺是通过以下技术方案实现的：
一种慢性肾病患者用的特殊医用食品配方，其特征在于：按照重量份数比，包括:麦芽糊精90-110、植物性油粉80-100、芥花油粉50-60、菊糖3-5、蔗糖3-5、碳酸钙0.08-0.1、氯化钠1-3、香草精0.5-0.7、碳酸镁0.001-0.003、氯化钾0.001-0.003、磷酸钙0.001-0.003、碳酸氢钠0.001-0.003、磷酸镁0.001-0.003、二氧化锡0.001-0.003、抗坏血酸钠0.05-0.06、重酒石酸胆碱0.1-0.3、乙酸维生素E0.00005-0.00008、硫酸锌0.00004-0.00008、硫酸铁0.00004-0.00008、硫酸锰0.00005-0.00007、焦磷酸铁0.00003-0.00005、本多酸钙0.00003-0.00008、氟化钠0.00005-0.00008、维生素K1 0.00007-0.00009、维生素D30.00005-0.00008、硫酸铜0.0000005-0.0000007、亚硒酸钠0.0000005-0.0000007、维生素A棕桐酸酯0.02-0.04、生物素、氧化锌0.0000005-0.0000009、维生素B120.0000005-0.0000009、维生素B60.0000005-0.0000007、维生素B20.0000005-0.0000009、维生素B10.0000005-0.0000008、乙酸维生素A0.0000005-0.0000008、叶酸0.0004-0.0008、碘化钾0.0000005-0.0000007、β-胡萝卜素0.0005-0.0009、三氯化铬0.0000005-0.0000007、钼酸钠0.0000005-0.0000007。
所述植物性油粉由玉米糖浆固形物、棕桐油、干酪素钠、脂肪酸甘油酯、乳酸硬脂酸钠、磷酸氢二钾、二氧化矽、碳酸钠、天然食用色素混合而成。
所述芥花油粉由玉米糖浆固形物、芥花油、干酪素钠、蔗糖、脂肪酸甘油酯、磷酸氢二钾、二氧化矽、矽树脂、香料、抗氧化剂混合而成。
所述维生素A棕桐酸酯由麦芽糊精、阿拉伯胶、蔗糖、维生素A、棕桐酸酯、抗氧化剂、磷酸钙混合而成。
一种慢性肾病患者用的特殊医用食品生产工艺，其特征在于，包括以下步骤：A、将固体颗粒进行循环研磨10min，形成粉末；
B、将形成的粉末与其他物质混合，采用螺旋搅拌机充分搅拌5min，形成粉状产品；
C、将粉状产品进行抽样成分检查，若检测不合格，则重复B步骤，若检测合格则进行包装，做成成品。
本发明的有益效果是：本产品低蛋白、高能量，能保证慢性肾脏病患者营养物质供给，显著改善CKD患者营养状况，延缓CKD进展，提高生活质量，提高生存率；高能量，高效补充CKD患者的能量缺失；小容量的液体负荷，不增加肾脏负担，适合慢性肾脏病人的能量补充；高维生素E和高维生素K1可有效抗氧化和抗血管钙化；依从性良好，每日仅需3-4次，每次剂量30ml，可为患者提供600 kcal能量；添加到正常饮食或肠内营养方案中，与开水同服，使用方便。
具体实施方式
下面将通过实施例对本发明的技术方案进行清楚、完整地描述，显然，所描述的实施例仅是本发明的一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1：
一种慢性肾病患者用的特殊医用食品配方，按照重量份数比，包括:麦芽糊精90、植物性油粉80、芥花油粉50、菊糖3、蔗糖3、碳酸钙0.08、氯化钠1、香草精0.5、碳酸镁0.001、氯化钾0.001、磷酸钙0.001、碳酸氢钠0.001、磷酸镁0.001、二氧化锡0.001、抗坏血酸钠0.05、重酒石酸胆碱0.1、乙酸维生素E0.00005、硫酸锌0.00004、硫酸铁0.00004、硫酸锰0.00005、焦磷酸铁0.00003、本多酸钙0.00003、氟化钠0.00005、维生素K1 0.00007、维生素D30.00005、硫酸铜0.0000005、亚硒酸钠0.0000005、维生素A棕桐酸酯0.02、生物素、氧化锌0.0000005、维生素B120.0000005、维生素B60.0000005、维生素B20.0000005、维生素B10.0000005、乙酸维生素A0.0000005、叶酸0.0004、碘化钾0.0000005、β-胡萝卜素0.0005、三氯化铬0.0000005、钼酸钠0.0000005。
实施例2：
一种慢性肾病患者用的特殊医用食品配方，按照重量份数比，包括:麦芽糊精100、植物性油粉90、芥花油粉55、菊糖4、蔗糖4、碳酸钙0.09、氯化钠2、香草精0.6、碳酸镁0.002、氯化钾0.002、磷酸钙0.002、碳酸氢钠0.002、磷酸镁0.002二氧化锡0.002、抗坏血酸钠0.055、重酒石酸胆碱0.2、乙酸维生素E0.000065、硫酸锌0.00006、硫酸铁0.00006、硫酸锰0.00006、焦磷酸铁0.00004、本多酸钙0.000055、氟化钠0.000065、维生素K1 0.00008、维生素D30.000065、硫酸铜0.0000006、亚硒酸钠0.0000006、维生素A棕桐酸酯0.06、生物素、氧化锌0.0000007、维生素B120.0000007、维生素B60.0000006、维生素B20.0000007、维生素B10.00000065、乙酸维生素A0.00000065、叶酸0.0006、碘化钾0.0000006、β-胡萝卜素0.0007、三氯化铬0.0000006、钼酸钠0.0000006。
实施例3：
一种慢性肾病患者用的特殊医用食品配方，按照重量份数比，包括:麦芽糊精110、植物性油粉100、芥花油粉60、菊糖5、蔗糖5、碳酸钙0.1、氯化钠3、香草精0.7、碳酸镁0.003、氯化钾0.003、磷酸钙0.003、碳酸氢钠0.003、磷酸镁0.003、二氧化锡0.003、抗坏血酸钠0.06、重酒石酸胆碱0.3、乙酸维生素E0.00008、硫酸锌0.00008、硫酸铁0.00008、硫酸锰0.00007、焦磷酸铁0.00005、本多酸钙0.00008、氟化钠0.00008、维生素K1 0.00009、维生素D30.00008、硫酸铜0.0000007、亚硒酸钠0.0000007、维生素A棕桐酸酯0.04、生物素、氧化锌0.0000009、维生素B120.0000009、维生素B6-0.0000007、维生素B20.0000009、维生素B10.0000008、乙酸维生素A0.0000008、叶酸0.0008、碘化钾0.0000007、β-胡萝卜素0.0009、三氯化铬0.0000007、钼酸钠0.0000007。
实施例4：
一种慢性肾病患者用的特殊医用食品生产工艺，包括以下步骤：
A、将固体颗粒进行循环研磨10min，形成粉末；
B、将形成的粉末与其他物质混合，采用螺旋搅拌机充分搅拌5min，形成粉状产品；
C、将粉状产品进行抽样成分检查，若检测不合格，则重复B步骤，若检测合格则进行包装，做成成品。
以上所述实施例仅表示本发明的实施方式，其描述较为具体和详细，但并不能理解为对本发明范围的限制。应当指出的是，对于本领域的技术人员来说，在不脱离本发明构思的前提下，还可以做出若干变形和改进，这些都属于本发明保护范围。
Claims (5)
1.一种慢性肾病患者用的特殊医用食品配方，其特征在于：按照重量份数比，包括:麦芽糊精90-110、植物性油粉80-100、芥花油粉50-60、菊糖3-5、蔗糖3-5、碳酸钙0.08-0.1、氯化钠1-3、香草精0.5-0.7、碳酸镁0.001-0.003、氯化钾0.001-0.003、磷酸钙0.001-0.003、碳酸氢钠0.001-0.003、磷酸镁0.001-0.003、二氧化锡0.001-0.003、抗坏血酸钠0.05-0.06、重酒石酸胆碱0.1-0.3、乙酸维生素E0.00005-0.00008、硫酸锌0.00004-0.00008、硫酸铁0.00004-0.00008、硫酸锰0.00005-0.00007、焦磷酸铁0.00003-0.00005、本多酸钙0.00003-0.00008、氟化钠0.00005-0.00008、维生素K10.00007-0.00009、维生素D30.00005-0.00008、硫酸铜0.0000005-0.0000007、亚硒酸钠0.0000005-0.0000007、维生素A棕桐酸酯0.02-0.04、生物素、氧化锌0.0000005-0.0000009、维生素B120.0000005-0.0000009、维生素B60.0000005-0.0000007、维生素B20.0000005-0.0000009、维生素B10.0000005-0.0000008、乙酸维生素A0.0000005-0.0000008、叶酸0.0004-0.0008、碘化钾0.0000005-0.0000007、β-胡萝卜素0.0005-0.0009、三氯化铬0.0000005-0.0000007、钼酸钠0.0000005-0.0000007。
2.根据权利要求1所述的一种慢性肾病患者用的特殊医用食品配方，其特征在于：所述植物性油粉由玉米糖浆固形物、棕桐油、干酪素钠、脂肪酸甘油酯、乳酸硬脂酸钠、磷酸氢二钾、二氧化矽、碳酸钠、天然食用色素混合而成。
3.根据权利要求1所述的一种慢性肾病患者用的特殊医用食品配方，其特征在于：所述芥花油粉由玉米糖浆固形物、芥花油、干酪素钠、蔗糖、脂肪酸甘油酯、磷酸氢二钾、二氧化矽、矽树脂、香料、抗氧化剂混合而成。
4.根据权利要求1所述的一种慢性肾病患者用的特殊医用食品配方，其特征在于：所述维生素A棕桐酸酯由麦芽糊精、阿拉伯胶、蔗糖、维生素A、棕桐酸酯、抗氧化剂、磷酸钙混合而成。
5.一种慢性肾病患者用的特殊医用食品生产工艺，其特征在于，包括以下步骤：
A、将固体颗粒进行循环研磨10min，形成粉末；
B、将形成的粉末与其他物质混合，采用螺旋搅拌机充分搅拌5min，形成粉状产品；
C、将粉状产品进行抽样成分检查，若检测不合格，则重复B步骤，若检测合格则进行包装，做成成品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610762760.5A CN106343566A (zh) | 2016-08-30 | 2016-08-30 | 一种慢性肾病患者用的特殊医用食品配方及其生产工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610762760.5A CN106343566A (zh) | 2016-08-30 | 2016-08-30 | 一种慢性肾病患者用的特殊医用食品配方及其生产工艺 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106343566A true CN106343566A (zh) | 2017-01-25 |
Family
ID=57856267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610762760.5A Pending CN106343566A (zh) | 2016-08-30 | 2016-08-30 | 一种慢性肾病患者用的特殊医用食品配方及其生产工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106343566A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700089258A1 (it) * | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| CN115721670A (zh) * | 2021-08-27 | 2023-03-03 | 深圳奥萨制药有限公司 | 一种辅助防治慢性肾脏病的组合物 |
| US12297406B2 (en) | 2019-05-27 | 2025-05-13 | Alesco S.R.L. | Method for preparing a composition comprising cetylated fatty acids |
| US12383525B2 (en) | 2019-05-27 | 2025-08-12 | Pharmanutra S.P.A. | Compositions comprising cetylated fatty acids and use thereof for the treatment of arthritis and joint inflammatory conditions |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103874425A (zh) * | 2011-08-16 | 2014-06-18 | 雅培制药有限公司 | 转化膳食的方法 |
| CN104082662A (zh) * | 2014-07-23 | 2014-10-08 | 中恩（天津）营养科技有限公司 | 需要透析的慢性肾病患者适用的营养液及制备方法 |
| CN105211884A (zh) * | 2015-08-25 | 2016-01-06 | 广州金酮医疗科技有限公司 | 供糖尿病肾病患者透析后食用的营养组合物及其制备方法 |
| CN105286020A (zh) * | 2015-09-17 | 2016-02-03 | 广州市红十字会医院 | 一种非透析患者用营养组合物 |
| CN105559071A (zh) * | 2016-01-12 | 2016-05-11 | 刘保惠 | 一种适用于肾病的特殊医学用途配方食品及其制备方法 |
| CN106061291A (zh) * | 2013-12-18 | 2016-10-26 | 雅培公司 | 使用绿茶提取物来增加骨骼肌蛋白质合成的方法 |
-
2016
- 2016-08-30 CN CN201610762760.5A patent/CN106343566A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103874425A (zh) * | 2011-08-16 | 2014-06-18 | 雅培制药有限公司 | 转化膳食的方法 |
| CN106061291A (zh) * | 2013-12-18 | 2016-10-26 | 雅培公司 | 使用绿茶提取物来增加骨骼肌蛋白质合成的方法 |
| CN104082662A (zh) * | 2014-07-23 | 2014-10-08 | 中恩（天津）营养科技有限公司 | 需要透析的慢性肾病患者适用的营养液及制备方法 |
| CN105211884A (zh) * | 2015-08-25 | 2016-01-06 | 广州金酮医疗科技有限公司 | 供糖尿病肾病患者透析后食用的营养组合物及其制备方法 |
| CN105286020A (zh) * | 2015-09-17 | 2016-02-03 | 广州市红十字会医院 | 一种非透析患者用营养组合物 |
| CN105559071A (zh) * | 2016-01-12 | 2016-05-11 | 刘保惠 | 一种适用于肾病的特殊医学用途配方食品及其制备方法 |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700089258A1 (it) * | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| WO2019025922A1 (en) * | 2017-08-02 | 2019-02-07 | Pharmanutra S.P.A. | COMPOSITION FOR USE IN PREVENTING AND TREATING IRON DEFICIENCY |
| US20200246377A1 (en) * | 2017-08-02 | 2020-08-06 | Pharmanutra S.P.A. | Composition for use in the prevention and in the treatment of iron deficiency |
| US12246036B2 (en) * | 2017-08-02 | 2025-03-11 | Pharmanutra S.P.A. | Composition for use in the prevention and in the treatment of iron deficiency |
| US12297406B2 (en) | 2019-05-27 | 2025-05-13 | Alesco S.R.L. | Method for preparing a composition comprising cetylated fatty acids |
| US12383525B2 (en) | 2019-05-27 | 2025-08-12 | Pharmanutra S.P.A. | Compositions comprising cetylated fatty acids and use thereof for the treatment of arthritis and joint inflammatory conditions |
| CN115721670A (zh) * | 2021-08-27 | 2023-03-03 | 深圳奥萨制药有限公司 | 一种辅助防治慢性肾脏病的组合物 |
| CN115721670B (zh) * | 2021-08-27 | 2023-12-29 | 深圳奥萨制药有限公司 | 一种辅助防治慢性肾脏病的组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104000166B (zh) | 一种彩色功能调味低钠液盐及其制备方法 | |
| CN106343566A (zh) | 一种慢性肾病患者用的特殊医用食品配方及其生产工艺 | |
| CN105077268A (zh) | 一种含有多种维生素和植物提取物以及微量元素的软胶囊制剂及其制备方法 | |
| CN103238675A (zh) | 一种油茶籽油亚麻籽油复配微胶囊的制备方法 | |
| CN103989059A (zh) | 富含功能肽铁锌营养面条 | |
| CN103652540A (zh) | 一种微胶囊配方 | |
| CN101971951A (zh) | 一种具有保健功能的山药粉及制备方法 | |
| CN103919208A (zh) | 红枣复合饮料及其制备方法 | |
| CN105455133A (zh) | 一种预消化型全营养液及其制备方法 | |
| CN103652931A (zh) | 一种用于饮料微胶囊配方 | |
| CN102178321B (zh) | 一种女性人群特殊膳食红色即冲饮品及加工方法 | |
| CN101032266A (zh) | 一种富含类胡萝卜素的芝麻油及其生产方法 | |
| CN102934701A (zh) | 一种银杏营养油及其制作方法 | |
| CN113349374A (zh) | 一种牡丹籽油肽微囊粉 | |
| CN106857885A (zh) | 一种安神养胃芝麻调和油 | |
| CN107006660A (zh) | 一种低热量亚麻籽油凝胶糖果 | |
| CN110742267A (zh) | 一种炎性肠病全营养配方食品 | |
| CN104187313A (zh) | 一种营养助消化的1段婴幼儿米粉 | |
| CN104799298A (zh) | 一种以虾青素与欧米伽3结合的营养补充液 | |
| CN104381784A (zh) | 产后妇女粉丝及其制作方法 | |
| CN103621895A (zh) | 生姜面条及其制作方法 | |
| CN107467193A (zh) | 一种以羊奶为基础的粉剂全营养特殊医学用途配方食品及其制备方法 | |
| CN118901985A (zh) | 一种高必需脂肪含量的婴幼儿营养米粉及其制备方法 | |
| CN102228279B (zh) | 莲芡营养饮品及其制作方法 | |
| CN105325745A (zh) | 一种中草药蛋鸡饲料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170125 |